Form 4: Guardant Health Executive Chris Freeman Reports Stock Transactions
SEC Form 4 Filing
Chris Freeman, Chief Commercial Officer of Guardant Health, reports the vesting and subsequent tax withholding of restricted stock units.
Summary
- On January 1, 2025, Chris Freeman, Chief Commercial Officer of Guardant Health, Inc., reported transactions involving common stock and restricted stock units.
- Freeman acquired 1,928 shares and 1,667 shares of common stock through the vesting of restricted stock units.
- 1,183 shares were withheld by the company to cover tax obligations related to the vesting of the restricted stock units at a price of $30.55.
- Following these transactions, Freeman directly owns 34,669 shares of common stock, 13,499 restricted stock units from a November 7, 2022 grant, and 11,671 restricted stock units from a December 13, 2023 grant.
Sentiment
Score: 5
Explanation: This is a routine filing related to executive compensation and doesn't indicate any significant positive or negative sentiment.
Positives
- The vesting of restricted stock units indicates a continued investment in the company by the executive.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions, which are closely monitored by investors.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units that vest over time to align executive interests with long-term shareholder value.
- Tax withholding practices related to vesting are standard procedure.
Stakeholder Impact
- Shareholders can monitor insider transactions through Form 4 filings to gain insights into management's perspective on the company's value.
Key Dates
| Date | Description |
|---|---|
| November 7, 2022 | Date of restricted stock unit award that vests over a four-year period. |
| December 13, 2023 | Date of restricted stock unit award that vests over a three-year period. |
| October 1, 2023 | 25% of the shares subject to the November 7, 2022 award vested. |
| October 1, 2024 | 33% of the shares subject to the December 13, 2023 award vested. |
| January 1, 2025 | Date of reported transactions: vesting of restricted stock units and tax withholding. |
| January 3, 2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.